Titolo/oggetto del contratto di sperimentazione
A multicenter, randomized, double-bind, active-controlled, parallelgroup Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high riskpatients following an acute myocardial infarction